Literature DB >> 25755602

Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma.

Shashi B Paul1, Hanish Sharma2.   

Abstract

Transcatheter intra-arterial therapies play a vital role in treatment of HCC due to the unique tumor vasculature. Evolution of techniques and newer efficacious modalities of tumor destruction have made these techniques popular. Various types of intra-arterial therapeutic options are currently available. These constitute: bland embolization, trans-arterial chemotherapy, trans-arterial chemo embolization with or without drug-eluting beads and trans-arterial radio embolization, which are elaborated in this review.

Entities:  

Keywords:  AFP, alpha feto protein; CR, complete response; HAIC, hepatic artery infusion chemotherapy; HCC, hepatocellular carcinoma; LA, laser ablation; OLT, orthotopic liver transplant; PD, progressive disease; PEI, percutaneous ethanol injection; PR, partial response; PVT, portal vein thrombosis; RFA, ablation; SD, stable disease; TACE, trans-arterial chemoembolization; TAE, Trans-arterial embolization; TART, trans-arterial radiotherapy; drug eluting bead (DEB); hepatocellular carcinoma (HCC); trans-arterial chemoembolization (TACE); trans-arterial embolization (TAE); trans-arterial radiotherapy (TART)

Year:  2014        PMID: 25755602      PMCID: PMC4284218          DOI: 10.1016/j.jceh.2014.03.048

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  110 in total

1.  Transcatheter arterial chemoembolization of hepatocellular carcinoma.

Authors:  J W Chung
Journal:  Hepatogastroenterology       Date:  1998-08

2.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

3.  A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

Authors:  L Lladó; J Virgili; J Figueras; C Valls; J Dominguez; A Rafecas; J Torras; J Fabregat; J Guardiola; E Jaurrieta
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

4.  Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents.

Authors:  K Takayasu; Y Shima; Y Muramatsu; N Moriyama; T Yamada; M Makuuchi; H Hasegawa; S Hirohashi
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

Review 5.  Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.

Authors:  Roberto S Oliveri; Jørn Wetterslev; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

6.  Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study.

Authors:  E Bobbio-Pallavicini; C Porta; M Moroni; G Bertulezzi; L Civelli; P Pugliese; G Nastasi
Journal:  Eur J Cancer       Date:  1997-10       Impact factor: 9.162

7.  Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma.

Authors:  Thomas Decaens; Françoise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; Jean Gugenheim; Francois Durand; Pierre-Henri Bernard; Olivier Boillot; Karim Boudjema; Yvon Calmus; Jean Hardwigsen; Christian Ducerf; Georges Philippe Pageaux; Sebastien Dharancy; Olivier Chazouilleres; Daniel Dhumeaux; Daniel Cherqui; Christophe Duvoux
Journal:  Liver Transpl       Date:  2005-07       Impact factor: 5.799

Review 8.  Palliative treatment in advanced hepatocellular carcinoma: has it made any difference?

Authors:  Shashi B Paul; Y C Manjunatha; Subrat K Acharya
Journal:  Trop Gastroenterol       Date:  2009 Jul-Sep

9.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Laura M Kulik; Brian I Carr; Mary F Mulcahy; Robert J Lewandowski; Bassel Atassi; Robert K Ryu; Kent T Sato; Al Benson; Albert A Nemcek; Vanessa L Gates; Michael Abecassis; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

View more
  8 in total

1.  Current strategies in interventional oncology of colorectal liver metastases.

Authors:  Tatjana Gruber-Rouh; Christian Marko; Axel Thalhammer; Nour-Eldin Nour-Eldin; Marcel Langenbach; Martin Beeres; Nagy N Naguib; Stephan Zangos; Thomas J Vogl
Journal:  Br J Radiol       Date:  2016-05-26       Impact factor: 3.039

2.  Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.

Authors:  Farnaz Najmi Varzaneh; Ankur Pandey; Mounes Aliyari Ghasabeh; Nannan Shao; Pegah Khoshpouri; Pallavi Pandey; Manijeh Zarghampour; Daniel Fouladi; Robert Liddell; Robert Albert Anders; Ihab R Kamel
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

3.  A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks.

Authors:  Minhyung Kim; Colin A Powers; Leslie I Curtin; Daniel T Fisher; Sandra Sexton; Katerina V Gurova; Joseph J Skitzki; Renuka V Iyer
Journal:  J Surg Res       Date:  2020-03-03       Impact factor: 2.192

Review 4.  Contrast-enhanced ultrasound (CEUS) in HCC diagnosis and assessment of tumor response to locoregional therapies.

Authors:  John R Eisenbrey; Helena Gabriel; Esika Savsani; Andrej Lyshchik
Journal:  Abdom Radiol (NY)       Date:  2021-04-07

5.  US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial.

Authors:  John R Eisenbrey; Flemming Forsberg; Corinne E Wessner; Lauren J Delaney; Kristen Bradigan; Sriharsha Gummadi; Mohamed Tantawi; Andrej Lyshchik; Patrick O'Kane; Ji-Bin Liu; Charles Intenzo; Jesse Civan; Warren Maley; Scott W Keith; Kevin Anton; Allison Tan; Amanda Smolock; Susan Shamimi-Noori; Colette M Shaw
Journal:  Radiology       Date:  2020-12-15       Impact factor: 11.105

6.  Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy.

Authors:  Yanxia Gong; Jie Zhang; Xiang Wu; Tao Wang; Jia Zhao; Zhi Yao; Qingyu Zhang; Xi Liu; Xu Jian
Journal:  Oncol Lett       Date:  2017-08-04       Impact factor: 2.967

7.  Improved therapeutic outcomes of thermal ablation on rat orthotopic liver allograft sarcoma models by radioiodinated hypericin induced necrosis targeted radiotherapy.

Authors:  Long Gao; Jian Zhang; Tengchuang Ma; Nan Yao; Meng Gao; Xin Shan; Yicheng Ni; Haibo Shao; Ke Xu
Journal:  Oncotarget       Date:  2016-08-09

8.  Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.

Authors:  Jian Gao; Rui Zhen; Hai Liao; Wenquan Zhuang; Wenbo Guo
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.